Columnist Anna Jeter shares her journey of embracing visibility and redefining her own definition of disabled after a ...

Apelin delivered by extracellular vesicles to damaged lungs was found to ease PAH in animal models of the disease, per a ...

Columnist Jen Cueva talks with fellow patient Jolie Lizana about her journey to becoming a patient advocate and columnist for ...

A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment seralutinib.

My name is James Ramsey. I decided to rejoin my gym in 2018, and after working out, I began feeling dizzy. It lasted for two days, at which point I wasn’t feeling right, so I went to the emergency ...